Dr. Jian Qiao completed her Ph.D. at the Chinese Medical University in China.  During her post-doctoral research training at Mount Sinai in New York (with Dr. Savio Woo) as well as the Cancer Center at Laval University in Canada (with Dr. Manuel Caruso), Dr. Qiao had been working on the development of novel and translational gene/cell- based therapy and oncolytic virotherapy for cancer.  From 2002-2006 she served as as Senior Research Fellow in the Molecular Medicine Program at Mayo and between 2008-2012 was an Assistant Professor of Biochemistry and Molecular Biology at the  Mayo Clinic.  Her work, which spans over thirty publications,  has been featured in Nature Medicine, Clinical Cancer Research, and Gene Therapy and she is the past recipient of NIH awards.    Dr. Qiao’s recent work had been focusing on using either classical chemotherapy drugs or the newly developed anticancer agents to enhance virotherapy through modulating innate and adaptive antiviral immune response, conditioning tumor microvasculature, or/ and sensitizing tumor cell death (oncolysis).  In Dr. Lesniak’s lab, Dr. Qiao currently focuses on the studies of immunity in the context of brain cancer and virotherapy.

View a partial list of Dr. Qiao's publications through the National Library of Medicine's PubMed online database.

Email: [email protected]

---